Home

Gilead Announces Results of FDA Advisory Committee Meetings
FDA Advisory Committee Supports Approval of Gilead’s Once-Daily Quad Single Tablet Regimen Read Press Release FDA Advisory Committee Supports Approval of Gilead’s Truvada® for Reducing the Risk of Acquiring HIV Read Press Release

News

Events

May 18 - 23, 2012
American Thoracic Society International Conference
San Francisco, CA
June 4 - 7, 2012
Jefferies & Company 2012 Global Healthcare Conference
New York, NY
June 5 - 7, 2012
Goldman Sachs 33rd Annual Healthcare Conference
Rancho Palos Verdes, CA
June 6 - 9, 2012
35th European Cystic Fibrosis Conference
Dublin, Ireland
June 12 - 14, 2012
32nd Annual William Blair Growth Stock Conference
Chicago, IL
View all events

Patient Access

Gilead is committed to ensuring that a drug's price is never a barrier to access. We support a number of programs that help ensure patients who need our therapies have access to them.
Learn more

Gilead Careers and Culture

Our greatest asset is our employees – not only their individual skills, expertise and vision, but their inspired personal commitment to our mission of making a difference in the lives of patients suffering from serious unmet medical needs.
Learn more

Gilead Worldwide

Today, we have approximately 4,500 employees and operations in North America and several countries throughout Europe and Australia.
Learn more

Products and Clinical Research